The application of Ferroptosis in diseases

Qiu, Yangmin, Cao, Yue, Cao, Wangjia, Jia, Yifei, Lu, Na·2020·Pharmacological Research

Cites (211)

Items 201–207 of 207

  1. Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition
    Jong‐Lyel Roh, Eun Hye Kim, Hye-Jin Jang, Daiha Shin · 2017 · Free Radical Biology and Medicine
  2. A mechanopharmacology approach to overcome chemoresistance in pancreatic cancer
    Stefano Coppola, Ilaria Carnevale, Erik H.J. Danen, Godefridus J. Peters, Thomas Schmidt, Yehuda G. Assaraf, Elisa Giovannetti · 2017 · Drug Resistance Updates
  3. Iron Chelation Therapy in Hereditary Hemochromatosis and Thalassemia Intermedia: Regulatory and Non Regulatory Mechanisms of Increased Iron Absorption
    George John Kontoghiorghes, Aspasia Spyrou, Annita Kolnagou · 2010 · Hemoglobin
  4. Contrasting intra- and extracellular distribution of catalytic ferrous iron in ovalbumin-induced peritonitis
    Ito, Fumiya, Nishiyama, Takahiro, Shi, Lei, Mori, Masahiko, Hirayama, Tasuku, Nagasawa, Hideko, Yasui, Hiroyuki, Toyokuni, Shinya · 2016 · Biochemical and Biophysical Research Communications
  5. Association between Serum Iron and the Severity of Coronary Artery Disease.
    Babak Bagheri, Mohammad Shokrzadeh, Vahid Mokhberi, Soheil Azizi, Alireza Khalilian, Negin Akbari, Valiallah Habibi, Keyvan Yousefnejad, Sasan Tabiban, Maryam Nabati · 2013 · Europe PMC (PubMed Central)
  6. Genetic Approaches to Analyzing Mitochondrial Outer Membrane Permeability
    Brett H. Graham, William James Craigen · 2004 · Current topics in developmental biology/Current Topics in Developmental Biology
  7. Iron-mediated oxidative cell death is a potential contributor to neuronal dysfunction induced by neonatal hemolytic hyperbilirubinemia
    Alena Viktorínová · 2018 · Archives of Biochemistry and Biophysics